Logo

Michael Taylor

May 08, 2008
Premium
Cequent Pharmaceuticals has appointed Michael Taylor to its board of directors.
 
Taylor is president and CEO of Ensemble Discovery, a biotechnology firm developing drugs and assays. Previously, he was senior vice president for Pfizer’s global research and development division.
 
He holds a PhD in medicinal chemistry from the State University of New York at Buffalo.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.